AMYLEX PHARMACEUTICALS INC has a total of 12 patent applications. Its first patent ever was published in 2013. It filed its patents most often in China, Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are BIOPHERESIS TECHNOLOGIES INC, FERRING ARZNEIMITTEL GMBH and RIGSHOSPITALET COPENHAGEN UNIV HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | Republic of Korea | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hungary | 1 | |
#7 | India | 1 | |
#8 | Serbia | 1 | |
#9 | Singapore | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Syringes | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kasinathan Chinnaswamy | 12 |
#2 | Stein Stanley | 12 |
#3 | Santos Rogelio B Jr | 8 |
#4 | Santos Jr Rogelio B | 3 |
#5 | Santos Rogelio | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013162387A1 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof | |
HUE040064T2 | Novel composition for extracorporeal reduction of beta-amyloids and process for producing thereof |